Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject who completed the A1481244 study and are judged by the Investigator to derive clinical benefit from continuous treatment with Sildenafil 20 mg therapy.
Subject who resides in a Brazilian State where Sildenafil is not supplied by State Health Secretary.
You may not be if
Pregnant or lactating women.
Current participation in other studies and during study participation.
Clareo Health | Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
